Developing better digital health measures of Parkinson’s disease using free living data and a crowdsourced data analysis challenge

Author:

Sieberts Solveig K.ORCID,Borzymowski Henryk,Guan Yuanfang,Huang Yidi,Matzner Ayala,Page AlexORCID,Bar-Gad IzharORCID,Beaulieu-Jones Brett,El-Hanani Yuval,Goschenhofer Jann,Javidnia Monica,Keller Mark S.,Li Yan-chak,Saqib MohammedORCID,Smith Greta,Stanescu Ana,Venuto Charles S.,Zielinski Robert,Jayaraman Arun,Evers Luc J. W.,Foschini Luca,Mariakakis Alex,Pandey Gaurav,Shawen Nicholas,Synder Phil,Omberg Larsson,

Abstract

One of the promising opportunities of digital health is its potential to lead to more holistic understandings of diseases by interacting with the daily life of patients and through the collection of large amounts of real-world data. Validating and benchmarking indicators of disease severity in the home setting is difficult, however, given the large number of confounders present in the real world and the challenges in collecting ground truth data in the home. Here we leverage two datasets collected from patients with Parkinson’s disease, which couples continuous wrist-worn accelerometer data with frequent symptom reports in the home setting, to develop digital biomarkers of symptom severity. Using these data, we performed a public benchmarking challenge in which participants were asked to build measures of severity across 3 symptoms (on/off medication, dyskinesia, and tremor). 42 teams participated and performance was improved over baseline models for each subchallenge. Additional ensemble modeling across submissions further improved performance, and the top models validated in a subset of patients whose symptoms were observed and rated by trained clinicians.

Funder

Michael J. Fox Foundation for Parkinson's Research

Publisher

Public Library of Science (PLoS)

Reference38 articles.

1. Remote smartphone monitoring of Parkinson’s disease and individual response to therapy;L Omberg;Nat Biotechnol,2021

2. Now you see me: The voice of people with Parkinson’s in clinical trials. AD/PD; 2019. Available: https://www.youtube.com/watch?v=Gj1iXHUWhSk

3. FDA rejects Verily’s filing for wearable Parkinson’s disease clinical trial tool. In: MobiHealthNews [Internet]. 16 Jun 2021 [cited 7 Oct 2021]. Available: https://www.mobihealthnews.com/news/fda-rejects-verilys-filing-wearable-parkinsons-disease-clinical-trial-tool

4. Real-World Evidence—What Is It and What Can It Tell Us?;RE Sherman;N Engl J Med,2016

5. Systematic Review Looking at the Use of Technology to Measure Free-Living Symptom and Activity Outcomes in Parkinson’s Disease in the Home or a Home-like Environment.;C Morgan;J Park Dis.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3